2025
SJR Q3
JCR Q4 · 0,8
125 matched articles
SCIE
Journal detail
Current HIV Research
- Publisher
- Bentham Science Publishers
- Country
- United Arab Emirates · Middle East
- Type
- journal
- ISSN
-
1570162X18734251
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,267
- Quartile Q3
- H-Index 61
- Cites/doc 0,83
- Docs (3y) 147
- Cites (3y) 123
Clarivate
Web of Science · JCR · 2025
- JCR Q Q4
- JIF 0,8
- 5Y JIF 0,9
- JCI 0,2
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Infectious Diseases Q3
- Virology Q3
WoS categories
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q4 | 0,267 | 0,8 | 0,9 | 0,2 | Q4 | 61 |
| 2024 | Q3 | Q4 | 0,288 | 1 | 1 | 0,19 | Q4 | 60 |
| 2023 | Q3 | Q4 | 0,301 | 0,8 | 1 | 0,17 | Q4 | 60 |
| 2022 | Q3 | Q4 | 0,296 | 1 | 1,1 | 0,18 | Q4 | 60 |
| 2021 | Q3 | Q4 | 0,422 | 1,3 | 1,5 | 0,23 | Q4 | 60 |
| 2020 | Q3 | Q4 | 0,561 | 1,6 | 1,6 | 0,25 | Q4 | 60 |
| 2019 | Q3 | Q4 | 0,588 | 0,8 | 1,4 | 0,28 | Q4 | 60 |
| 2018 | — | Q4 | — | 1,1 | 1,4 | 0,35 | Q4 | — |
| 2017 | Q2 | Q4 | 0,845 | 1,6 | 1,6 | 0,51 | Q3 | 60 |
| 2016 | Q2 | Q4 | 0,931 | 1,6 | 1,7 | — | — | 60 |
| 2015 | Q2 | Q3 | 0,984 | 1,6 | 1,6 | — | — | 60 |
| 2014 | Q2 | Q3 | 0,912 | 1,8 | 1,7 | — | — | 60 |
| 2013 | Q2 | Q3 | 1,044 | 2,1 | 1,9 | — | — | 60 |
| 2012 | Q2 | Q3 | 0,878 | 2 | 1,9 | — | — | 60 |
| 2011 | Q2 | Q3 | 0,833 | 1,7 | 2 | — | — | 60 |
| 2010 | Q2 | Q3 | 0,876 | 1,9 | 2 | — | — | 60 |
| 2009 | — | Q3 | — | 2 | 2,3 | — | — | — |
| 2008 | — | Q3 | — | 2,5 | 2,7 | — | — | — |
| 2007 | — | Q2 | — | 2,7 | 3 | — | — | — |
| 2006 | — | Q1 | — | 3,7 | — | — | — | — |
| 2005 | — | Q2 | — | 3 | — | — | — | — |
| 2004 | — | Q3 | — | 1,6 | — | — | — | — |
| 2003 | — | — | — | — | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | IMMUNOLOGY | SCIE | Q4 | Q4 | 177/183 |
| 2025 | INFECTIOUS DISEASES | SCIE | Q4 | Q4 | 130/141 |
| 2025 | VIROLOGY | SCIE | Q4 | Q4 | 44/44 |
| 2024 | IMMUNOLOGY | SCIE | Q4 | Q4 | 171/183 |
| 2024 | INFECTIOUS DISEASES | SCIE | Q4 | Q4 | 121/137 |
| 2024 | VIROLOGY | SCIE | Q4 | Q4 | 39/42 |
| 2023 | IMMUNOLOGY | SCIE | Q4 | Q4 | 172/181 |
| 2023 | INFECTIOUS DISEASES | SCIE | Q4 | Q4 | 119/132 |
| 2023 | VIROLOGY | SCIE | Q4 | Q4 | 40/41 |
| 2022 | IMMUNOLOGY | SCIE | Q4 | Q4 | 156/161 |
| 2022 | INFECTIOUS DISEASES | SCIE | Q4 | Q4 | 91/96 |
| 2022 | VIROLOGY | SCIE | Q4 | Q4 | 35/36 |
| 2021 | IMMUNOLOGY | SCIE | Q4 | Q4 | 157/162 |
| 2021 | INFECTIOUS DISEASES | SCIE | Q4 | Q4 | 90/95 |
| 2021 | VIROLOGY | SCIE | Q4 | Q4 | 36/37 |
| 2020 | IMMUNOLOGY | SCIE | Q4 | Q4 | 152/162 |
| 2020 | INFECTIOUS DISEASES | SCIE | Q4 | Q4 | 85/93 |
| 2020 | VIROLOGY | SCIE | Q4 | Q4 | 35/37 |
| 2019 | IMMUNOLOGY | SCIE | Q4 | Q4 | 154/159 |
| 2019 | INFECTIOUS DISEASES | SCIE | Q4 | Q4 | 87/92 |
| 2019 | VIROLOGY | SCIE | Q4 | Q4 | 35/37 |
| 2018 | IMMUNOLOGY | SCIE | Q4 | Q4 | 147/158 |
| 2018 | INFECTIOUS DISEASES | SCIE | Q4 | Q4 | 83/89 |
| 2018 | VIROLOGY | SCIE | Q4 | Q4 | 32/36 |
| 2017 | IMMUNOLOGY | SCIE | Q4 | Q4 | 136/155 |
| 2017 | INFECTIOUS DISEASES | SCIE | Q4 | Q3 | 72/88 |
| 2017 | VIROLOGY | SCIE | Q4 | Q3 | 28/35 |
| 2016 | IMMUNOLOGY | SCIE | Q4 | — | 128/151 |
| 2016 | INFECTIOUS DISEASES | SCIE | Q4 | — | 66/84 |
| 2016 | VIROLOGY | SCIE | Q4 | — | 27/34 |
| 2015 | IMMUNOLOGY | SCIE | Q4 | — | 130/151 |
| 2015 | INFECTIOUS DISEASES | SCIE | Q3 | — | 58/83 |
| 2015 | VIROLOGY | SCIE | Q4 | — | 26/33 |
| 2014 | IMMUNOLOGY | SCIE | Q4 | — | 121/148 |
| 2014 | INFECTIOUS DISEASES | SCIE | Q3 | — | 57/78 |
| 2014 | VIROLOGY | SCIE | Q4 | — | 26/33 |
| 2013 | IMMUNOLOGY | SCIE | Q3 | — | 103/144 |
| 2013 | INFECTIOUS DISEASES | SCIE | Q3 | — | 49/72 |
| 2013 | VIROLOGY | SCIE | Q3 | — | 22/33 |
| 2012 | IMMUNOLOGY | SCIE | Q3 | — | 102/137 |
| 2012 | INFECTIOUS DISEASES | SCIE | Q3 | — | 48/70 |
| 2012 | VIROLOGY | SCIE | Q3 | — | 23/34 |
| 2011 | IMMUNOLOGY | SCIE | Q4 | — | 114/139 |
| 2011 | INFECTIOUS DISEASES | SCIE | Q3 | — | 50/70 |
| 2011 | VIROLOGY | SCIE | Q4 | — | 26/32 |
| 2010 | IMMUNOLOGY | SCIE | Q4 | — | 103/134 |
| 2010 | INFECTIOUS DISEASES | SCIE | Q4 | — | 44/58 |
| 2010 | VIROLOGY | SCIE | Q3 | — | 23/33 |
| 2009 | IMMUNOLOGY | SCIE | Q3 | — | 96/128 |
| 2009 | INFECTIOUS DISEASES | SCIE | Q3 | — | 40/57 |
| 2009 | VIROLOGY | SCIE | Q3 | — | 21/30 |
| 2008 | IMMUNOLOGY | SCIE | Q3 | — | 70/121 |
| 2008 | INFECTIOUS DISEASES | SCIE | Q3 | — | 27/51 |
| 2008 | VIROLOGY | SCIE | Q3 | — | 15/27 |
| 2007 | IMMUNOLOGY | SCIE | Q2 | — | 58/119 |
| 2007 | INFECTIOUS DISEASES | SCIE | Q2 | — | 19/50 |
| 2007 | VIROLOGY | SCIE | Q3 | — | 14/25 |
| 2006 | IMMUNOLOGY | SCIE | Q2 | — | 33/117 |
| 2006 | INFECTIOUS DISEASES | SCIE | Q2 | — | 12/47 |
| 2006 | VIROLOGY | SCIE | Q1 | — | 5/23 |
| 2005 | IMMUNOLOGY | SCIE | Q2 | — | 42/115 |
| 2005 | INFECTIOUS DISEASES | SCIE | Q2 | — | 12/43 |
| 2005 | VIROLOGY | SCIE | Q2 | — | 11/23 |
| 2004 | IMMUNOLOGY | SCIE | Q3 | — | 78/111 |
| 2004 | INFECTIOUS DISEASES | SCIE | Q3 | — | 30/41 |
| 2003 | IMMUNOLOGY | SCIE | — | — | — |
| 2003 | INFECTIOUS DISEASES | SCIE | — | — | — |